Core C: The focus of Core C, Biostatistics and Pharmacology, is to provide biostatistics and pharmacology support to all projects in the application. The Core is composed of two complementary components. The first is a biostatistics design and analysis support component. All projects have experiments that have elements of variability in results, requiring statistical input. In addition, this Core will provide pharmacologic support in particular to Projects 3 and 4 but also for the IPCP as a whole.
Specific aims are:
Specific Aim 1 : To provide expertise and assistance on study design and statistical analysis. 1. Aid in the statistical components of the design of the experiments in Projects 1 and 2. 2. Develop statistical analysis plans for Projects 3 and 4. 3. Perform statistical analyses, summarize results and participate in dissemination for all 4 projects.
Specific Aim 2 : To provide pharmacokinetics (PK) and pharmacodynamic (PD) support 1. Develop an allometric model to predicts human exposure based on historical and Project 3 data 2. Perform pharamcokinetic/pharmacodynamic modeling using population pharmacokinetics approaches for data from both Projects 3 and 4 3. Create a clinical trial simulation for the subsequent clinical study after Project 4 4. Aid in the selection of other NK-1R antagonists based on Projects 1, 2 and Core B experiments in contributing the relevant pharmacological information.
Specific Aim 3 : To provide information systems and data management support 1. Design and maintain a database to accommodate all 4 projects and Core B, with appropriate permissions to enter/review data and allowing access from four geographical sites 2. Upload data as necessary, manage and correct data 3. Implement a data sharing plan.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Program Projects (P01)
Project #
5P01MH076388-02
Application #
7312699
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2006
Total Cost
$241,161
Indirect Cost
Name
Children's Hospital of Philadelphia
Department
Type
DUNS #
073757627
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Douglas, Steven D (2016) Substance P and sickle cell disease-a marker for pain and novel therapeutic approaches. Br J Haematol 175:187-188
Barrett, Jeffrey S; Spitsin, Sergei; Moorthy, Ganesh et al. (2016) Pharmacologic rationale for the NK1R antagonist, aprepitant as adjunctive therapy in HIV. J Transl Med 14:148
Tebas, Pablo; Spitsin, Sergei; Barrett, Jeffrey S et al. (2015) Reduction of soluble CD163, substance P, programmed death 1 and inflammatory markers: phase 1B trial of aprepitant in HIV-1-infected adults. AIDS 29:931-9
Barrett, Jeffrey S; Bajaj, Gaurav; McGuire, Jennifer et al. (2014) Modeling and simulation approach to support dosing and study design requirements for treating HIV-related neuropsychiatric disease with the NK1-R antagonist aprepitant. Curr HIV Res 12:121-31
Barrett, Jeffrey S; McGuire, Jennifer; Vezina, Heather et al. (2013) PET measurement of receptor occupancy as a tool to guide dose selection in neuropharmacology: are we asking the right questions? J Clin Psychopharmacol 33:725-8
Schwartz, Lynnae; Spitsin, Sergei V; Meshki, John et al. (2013) Substance P enhances HIV-1 infection in human fetal brain cell cultures expressing full-length neurokinin-1 receptor. J Neurovirol 19:219-27
McLaughlin, Sherry; Swenson, Luke C; Hu, Shengbo et al. (2013) Development of a novel codon-specific polymerase chain reaction for the detection of CXCR4-utilizing HIV type 1 subtype B. AIDS Res Hum Retroviruses 29:814-25
Spitsin, Sergei; Tuluc, Florin; Meshki, John et al. (2013) Analog of somatostatin vapreotide exhibits biological effects in vitro via interaction with neurokinin-1 receptor. Neuroimmunomodulation 20:247-55
Spitsin, Sergei; Stevens, Kathleen E; Douglas, Steven D (2013) Expression of substance P, neurokinin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology. J Neurol Sci 334:18-23
Khan, Mohammad M; Douglas, Steven D; Benton, Tami D (2012) Substance P-neurokinin-1 receptor interaction upregulates monocyte tissue factor. J Neuroimmunol 242:1-8

Showing the most recent 10 out of 37 publications